A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases

Condition:   Dermatomyositis, Polymyositis, Sjogren's, SLE, SScInterventions:   Biological: MEDI7734;   Biological: PlaceboSponsor:   MedImmune LLCNot yet recruiting - verified May 2016

Source: ClinicalTrials.gov - May 3, 2016 Category: Research Source Type: clinical trials